Related Experiment Video

Updated: Aug 19, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

[Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers]

J Q Cheng1, M Crépin, R Hamelin

  • 1Université de Paris-Nord, Institut d'Oncologie cellulaire et moléculaire humaine, Bobigny.

Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|January 1, 1990
PubMed

Insights

Lung cancer patients often experience antioncogene inactivation. This study identified frequent DNA deletions on chromosomes 1p, 3p, 11p, and 11q in non-small cell lung cancer cases.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Antioncogene inactivation, including Rb and p53 genes, is common in lung cancer.
  • Non-small cell lung cancer (NSCLC) comprises various histological subtypes.
  • Genetic alterations play a crucial role in lung cancer development.

Purpose:

  • To investigate the frequency and pattern of DNA sequence deletions in NSCLC.
  • To identify specific chromosomal regions frequently affected by allele loss in NSCLC patients.
  • To correlate genetic alterations with lung cancer subtypes.

Summary:

  • A study analyzed 48 NSCLC cases using restriction fragment length polymorphism (RFLP) analysis.
  • Significant DNA sequence deletions were found on chromosomes 1p32-36, 3p21, 11p15.5, and 11q13.
  • Allele loss frequencies were 31% (1p), 57% (3p), 20% (11p), and 49% (11q).
  • 19 tumors showed single allele loss, while 10 exhibited multiple allele losses across different chromosomes.

Impact:

  • Identifies specific chromosomal regions as potential tumor suppressor loci in NSCLC.
  • Provides insights into the genetic landscape of NSCLC, aiding in understanding tumorigenesis.
  • May inform future diagnostic or therapeutic strategies targeting genetic alterations in lung cancer.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...